Why ImmunityBio, Inc. (IBRX) Went Up On Wednesday? [Yahoo! Finance]

ImmunityBio, Inc. (IBRX)
Company Research
Source: Yahoo! Finance
ImmunityBio, Inc. (NASDAQ:IBRX) stands against stocks that stand strong amid cautious market environment. The stock market showed resilience on Wednesday, with all major indices ending in the green territory anew, as investors weighed news of President Donald Trump's imposition of a new round of tariffs while digesting minutes of the Federal Reserve. The Dow Jones rose by 0.16 percent, the S&P 500 increased by 0.24 percent, while the tech-heavy Nasdaq eked out a 0.07 percent gain. Despite the news, ten companies managed to stand out, posting modest gains during the trading session. To come up with Wednesday's top performers, we considered only the stocks with more than $1.9 billion in market capitalization and $5 million in dai
Read more
Impact Snapshot
Event Time:
IBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IBRX alerts
High impacting ImmunityBio, Inc. news events
Weekly update
A roundup of the hottest topics
IBRX
News
- ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial LaunchBusiness Wire
- BeiGene (NasdaqGS:ONC) Gains 32% In A Quarter Amid Positive EMA Opinion On TEVIMBRA [Yahoo! Finance]Yahoo! Finance
- ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.MarketBeat
- "This Is Existential": Billionaire Cancer Researcher Says Covid & Vaccine Likely Causing Surge In Aggressive Cancers [zero hedge]zero hedge
- ImmunityBio to Host Investor Day [Yahoo! Finance]Yahoo! Finance
IBRX
Earnings
- 11/12/24 - Beat
IBRX
Sec Filings
- 3/19/25 - Form 8-K
- 3/3/25 - Form 10-K
- 3/3/25 - Form 8-K
- IBRX's page on the SEC website